Tshepo Mokabane: From a VMMC Room to Hope
Tshepo Mokabane, Demand creation Coordinator at Pulse Health, shared a post on LinkedIn:
“From a VMMC room to hope, My friend’s hemophilia story
I met him as a program assistant for VMMC — Voluntary Medical Male Circumcision.
He was a child, and during that procedure our clinical team ran tests and found out he had hemophilia. From that day, I followed his journey.
I checked in on his healing, stayed in touch, and kept monitoring his recovery. Over time, the distance between program staff and patient faded. He became a friend.
For years after, his world felt small.
He would say, ‘What if I’m in an accident and I can’t stop bleeding?’
Fear kept him from traveling. He called himself ‘fragile,’ like he had to live in bubble wrap.
His mother worried every time he stepped outside.
Even a bruise felt like an emergency.
Hemophilia A and B mean the body doesn’t make enough clotting protein, factor VIII or factor IX, so bleeding lasts longer.
For decades that meant regular infusions and a life built around risk.
But now, something is shifting.
Gene therapy is here, a one time treatment that gives the liver a working copy of the missing gene.
The liver then makes the clotting protein on its own. Studies show it can last 5 and more years after one dose.
One therapy for hemophilia A is approved in Europe, and one for hemophilia B is under review.
Doctors still watch the liver in the first year, but the goal is bigger, fewer infusions, fewer emergencies, less fear.
When I told him about this, I saw hope again. Not a guarantee of zero risk, but a chance to stop living like glass. A chance to travel. A chance for his parents to breathe easier.
He started as a child I was supporting through VMMC.
He became a friend I’m rooting for.
From ‘I have to be careful’ to ‘Maybe I can live again.’
If you or someone you love has hemophilia, talk to a hematologist about gene therapy.”
Stay updated with Hemostasis Today.
-
Jul 3, 2026, 15:29Santosh Kumar Yadav: PF4 Emerges as a Central Player in Antiphospholipid Syndrome
-
Jul 3, 2026, 14:55Rabiah Alnoshan: The Importance of Pulse Examination in Acute Limb Ischemia
-
Jul 3, 2026, 14:44Carrie Gillies: Personal Experience Reinforces the Need for Timely DVT Diagnosis
-
Jul 3, 2026, 14:30Munazza Sikandar: Comparing Figure-of-Eight Sutures and Manual Compression for Safer Post-Ablation Care
-
Jul 3, 2026, 14:20Stefano Navarro: Partial GPVI Downregulation Shows Promise for Safer Antithrombotic Therapy
-
Jul 3, 2026, 13:31Javed Anees: TIA is a Medical Emergency – Not a Benign Warning
-
Jul 3, 2026, 12:46Heghine Khachatryan: 2026 AHA Guideline on the Management of CKM Syndrome
-
Jul 3, 2026, 12:32Shadi Tabibian: Beyond Bleeding – Women Living with von Willebrand Disease
-
Jul 3, 2026, 09:33Abdul Mannan: Not All Type 1 VWD Starts in the VWF Gene